Prognostic and Predictive Impact of uPA/PAI-1
NCT01317108
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
689
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
CMF Chemotherapy
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
[object Object]